Literature DB >> 33283340

Performance evaluation of immunoassay for infectious diseases on the Alinity i system.

Minjeong Nam1,2, Da Young Song1, Sang Hoon Song1, Eun Youn Roh3, Sue Shin3, Kyoung Un Park4, Eun Young Song1.   

Abstract

BACKGROUND: Although a diagnosis of infectious diseases is essential for timely treatment, the performance of diagnostic tests has been hardly evaluated due to variable results that are influenced by multiple factors in different conditions. In the present study, the performance of the Alinity i system, which is a newly developed immunoassay to diagnose infectious diseases, was evaluated.
METHODS: We evaluated the precision, linearity, correlation, and carryover of 16 analytes (HAV Ab IgG, HBsAg, HBeAg, anti-HBc, anti-HBe, anti-HBs, anti-HCV, HIV Ag/Ab, EBV VCA IgM, EBV VCA IgG, EBV EBNA IgG, CMV IgM, CMV IgG, Toxoplasma IgG, Rubella IgG, and Syphilis TP) of Alinity i by comparison with ARCHITECT i2000SR system following the rationale of the Clinical and Laboratory Standards Institute (CLSI).
RESULTS: For quantitative tests, the coefficients of variation (CV) % of repeatability and intermediate precision were between 0% and 4.18%. The coefficients of the linearity (r2 ) over a widely tested analytical range were ≥ 0.990 and the correlation between Alinity i and the ARCHITECT i2000SR system was strong (r ≥ 0.994). For qualitative tests, the agreement between Alinity i and the ARCHITECT i2000SR system was excellent (kappa coefficient 1) with 100% sensitivity and specificity. Carryover rates for all analytes were less than 1.0% (-0.11% ~ 0.21%).
CONCLUSION: The Alinity i system showed good analytical performance and favorable comparability with the ARCHITECT i2000SR. It could be suitable as a routine immunoassay analyzer for screening and diagnosis of infectious disease.
© 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

Entities:  

Keywords:  Alinity i system; analytical performance; comparison study; immunoassay; infectious disease

Year:  2020        PMID: 33283340     DOI: 10.1002/jcla.23671

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  2 in total

1.  Diagnosis of Congenital Toxoplasmosis: Performance of Four IgG and IgM Automated Assays at Birth in a Tricentric Evaluation.

Authors:  Marine Avignon; Maude F Lévêque; Emilie Guemas; Milène Sasso; Sahar Albaba; Laurence Lachaud; Judith Fillaux
Journal:  J Clin Microbiol       Date:  2022-05-02       Impact factor: 11.677

2.  Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection.

Authors:  Asako Murayama; Haruka Momose; Norie Yamada; Keiji Matsubayashi; Masamichi Muramatsu; Isao Hamaguchi; Takanobu Kato
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.